Posted by Michael Wonder on 10 Nov 2020
PHARMAC to fund new haemophilia medicine
11 November 2020 - From 1 December 2020 a new medicine will be funded by PHARMAC which will help some people with severe haemophilia A.
Emicizumab adds to the suite of haemophilia medicines that PHARMAC already funds, including two long acting treatments listed in 2019 for haemophilia A and B.
